TITLE

Simple and Sensitive Titrimetric and Spectrophotometric Determination of Enalapril Maleate in Pharmaceuticals using Permanganate

AUTHOR(S)
Vinay, Kanakapura Basavaiah; Revanasiddappa, Hosakere Doddarevanna; Shantala, Paraki Ravindra; Basavaiah, Kanakapura
PUB. DATE
July 2010
SOURCE
Eurasian Journal of Analytical Chemistry;2010, Vol. 5 Issue 2, p112
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
59903224

 

Related Articles

  • Development of a Spectrophotometric Method Based on Ferric Hydroxamate Reaction for Determination of Ramipril in Formulations. Ramu, B. Kalyana; Raghubabu, K.; Syambabu, M. // Indo Global Journal of Pharmaceutical Sciences;2011, Vol. 1 Issue 2, p152 

    A Simple, sensitive, extraction free and cost effective spectrophotometric method in visible region was developed for the estimation of Ramipril in bulk and dosage forms. The method is based on the ferric hydroxamate reaction purple red colored species is formed with hydroxylamine-ferric per...

  • Captoprilum.  // International Pharmacopoeia: Third Edition;2003, p54 

    Description of the cardiovascular agent "Captopril" is presented. The relative molecular mass, chemical name, description, solubility, category and storage of captopril are provided. It is informed that this substance may exist in different polymorphic forms. Tests for its identification are...

  • Development and validation of UV-Spectrophotometric method for determination of Enalapril maleate. Dubey, Sunil Kumar; Kumar, Sandeep; Mudakavi, Rajeev J.; Deshpande, Swapnil; Kumar Jain, Akash // International Journal of Advances in Pharmaceutical Sciences;Oct2010, Vol. 1 Issue 4, p375 

    The UV spectroscopic method of analysis is widely applicable for routine analytical procedure for determination of chemical compounds. Enalapril shows maximum absorbance at a wavelenght of 207nm, which is used in this study. The method provides a linear response from a quantitation range of...

  • Analysis of Binding Interaction between Captopril and Human Serum Albumin. Xiaoyan Gao; Yingcai Tang; Wanqi Rong; Xiaoping Zhang; Wujie Zhao; Yanqin Zi // American Journal of Analytical Chemistry;May2011, Vol. 2 Issue 2, p250 

    The interaction between captopril, an inhibitor of angiotensin converting enzyme and human serum albumin, a principal plasma protein in the liver has been investigated in vitro under a simulated physiological condition by UV-vis spectrophotometry and fluorescence spectrometry. The intrinsic...

  • Contribution of Captopril Thiol Group to the Prevention of Spontaneous Hypertension. Pechaáňova, O. // Physiological Research;2007 Supplement 2, Vol. 56, pS41 

    We aimed to compare the effect of angiotensin converting enzyme (ACE) inhibitors captopril (containing thiol group) and enalapril (without thiol group) on the development of spontaneous hypertension and to analyze mechanisms of their actions, particularly effects on oxidative stress and NO...

  • Nitric oxide and the renin angiotensin system: contributions to blood pressure in the young rat. Charbit, Marina; Blazy, Isabelle; Gogusev, Jean; Pouzet, Brigitte; Brocart, Dani�le; Sachs, Charles; D�chaux, Mich�le // Pediatric Nephrology;1997, Vol. 11 Issue 5, p617 

    The present study was designed to investigate the effects of chronic administration of the arginine analogue L-Name (50 mg/kg body weight), the angiotensin converting enzyme inhibitor, perindopril (2 mg/kg body weight), and perindopril (2 mg/kg) plus L-Name (50 mg/kg) on blood pressure, plasma...

  • The kallikrein-kinin system in diabetic nephropathy. Tomita, Hirofumi; Sanford, Ryan B; Smithies, Oliver; Kakoki, Masao // Kidney International;Apr2012, Vol. 81 Issue 8, p733 

    Diabetic nephropathy is the major cause of end-stage renal disease worldwide. Although the renin-angiotensin system has been implicated in the pathogenesis of diabetic nephropathy, angiotensin I-converting enzyme inhibitors have a beneficial effect on diabetic nephropathy independently of their...

  • Vasopeptidase Inhibition for Blood Pressure Control: Emerging Experience. Quaschning, Thomas // Current Pharmaceutical Design;Sep2005, Vol. 11 Issue 25, p3293 

    Vasopeptidase inhibition is a novel treatment approach in cardiovascular disease such as hypertension and heart failure. Since the inhibition of the angiotensin-converting enzyme (ACE) turned out to represent a very successful principle in the treatment of hypertension in numerous large scale...

  • Some disagreement over which heart attack patients should get ACE inhibitors.  // Modern Medicine;Nov94, Vol. 62 Issue 11, p16 

    Reports on the disagreement by speakers at a joint meeting of the World Congress of Cardiology and European Society of Cardiology in Berlin over which heart attack patient should get angiotensin-converting enzyme (ACE) inhibitors. GSS-3 study; ISIS-4 trial; Acute Infarction Ramipril Efficacy...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics